The notion that IFNα treatment failed to shape the vascular antimetastatic barrier in mice carrying the Ifnar1-deficiency only in endothelial cells further strengthens this hypothesis and places HECs/LSECs at a center of a relevant antitumor process ultimately limiting CRC liver invasion. This evidence concerns the gene IFNAR1 and colorectal carcinoma.